JPM
59
3
BXP
49
2
AMZN
61
2
RSG
62
2
HPQ
53
3
NTAP
54
2
HBI
52
2
DOV
61
4
HIG
54
2
UNH
55
5
ADBE
43
3
MAR
56
2
CA
16
3
GME
57
2
ALL
37
2
MDLZ
38
2
EMR
62
14
ECL
57
3
CSX
57
4
DHI
48
4
JPM
59
3
BXP
49
2
AMZN
61
2
RSG
62
2
HPQ
53
3
NTAP
54
2
HBI
52
2
DOV
61
4
HIG
54
2
UNH
55
5
ADBE
43
3
MAR
56
2
CA
16
3
GME
57
2
ALL
37
2
MDLZ
38
2
EMR
62
14
ECL
57
3
CSX
57
4
DHI
48
4
Financhill
Back

Amicus Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
63

FOLD
Amicus Therapeutics

Last Price:
11.30
Seasonality Move:
8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 15.9% based on the past 17 years of stock performance.
  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $11.74. The Score for FOLD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • FOLD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 15.9% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Buy
63
Amicus Therapeutics (FOLD) is a Buy

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • The current trend is moderately bearish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
14.57
52-Week Low:
9.02

Prediction Charts

Market Cap:
3.48B
Price in USD:
11.74
Volume:
1.97M
Beta:
1.02

Technical Analysis

SMA50:
11.14
SMA100:
10.83
SMA200:
11.13
52-Wk Change:
1.38%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 11.74 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 10.35 10.50 10.59 10.30
Oct-18 12.07 11.90 12.13 11.75
Oct-21 11.85 12.01 12.18 11.79
Oct-22 12.01 11.87 12.11 11.85
Oct-23 11.71 11.40 11.82 11.30
Oct-24 11.45 11.76 11.79 11.40
Oct-25 11.79 11.69 11.86 11.63
Oct-28 11.77 11.52 11.85 11.51
Oct-29 11.43 11.49 11.62 11.37
Oct-30 11.38 11.58 11.60 11.37
Oct-31 11.50 11.42 11.53 11.39
Nov-1 11.42 11.47 11.69 11.28
Nov-4 11.45 11.34 11.58 11.24
Nov-5 11.24 11.74 11.75 11.21

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and an increase next year of $0.28 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.